Read the side effects of Obinutuzumab as described in the medical literature. In case of any doubt consult your doctor or pharmacist.
Gastrointestinal: Diarrhea, constipation, indigestion, loss of appetite
Nervous system: Dizziness, confusion, difficulty in speech or to walk, loss of balance
Respiratory: Cough, nasal congestion,
sneezing, inflammation of the sinuses, nasopharyngitis
Musculoskeletal: Joint pain, pain in the extremities, muscle pain or cramps
Blood: Low levels of neutrophils, lymphocytes, white blood cells
Lab abnormalities: Decreased levels of calcium, potassium, sodium, and phosphate in the blood, increased liver enzymes, and creatinine levels
Others: Headache,
itching, fever, weakness, vision problems
Other Precautions : Breastfeeding mothers should be advised not to breastfeed their babies during and 18 months after the obinutuzumab treatment is stopped.
Women of reproductive potential living with active male partners should follow an effective contraceptive measure during obinutuzumab treatment and must continue the contraception for at least 18 months after the last dose of obinutuzumab.
Inspect the obinutuzumab vials and the diluted solution for the presence of any visible solid matter or discoloration before administering it to the patient.
